CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
until age 3.00 years to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodie...
Phase 2
Warsaw, Poland and 6 other locations
months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...
Warsaw, Poland and 7 other locations
study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participants with type 1 diabetes...
Phase 3
Warszawa, Mazowieckie, Poland and 76 other locations
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...
Phase 3
Warsaw, Poland and 58 other locations
This Phase 2 study is conducted to investigate the safety and efficacy of runcaciguat in the treatment of diabetic retinopathy. To assess ef...
Phase 2
Jozefow, Poland and 49 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Warsaw, Mazowieckie, Poland and 636 other locations
The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...
Phase 2
Warsaw, Poland and 37 other locations
This study will look at how much weight participants will lose and how much blood sugar control they achieve from the start to the end of the study....
Phase 3
Warszawa, Poland and 65 other locations
evaluate the efficacy, safety and pharmacokinetic (PK) properties of CPL207280 after multiple (14 days) administration in patients with type 2 diabetes...
Phase 2
Kajetany, Nadarzyn, Poland
We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. We are doi...
Phase 3
Warszawa, Poland and 32 other locations
Clinical trials
Research sites
Resources
Legal